atf6-gfp (#32955) (Addgene inc)
Structured Review

Atf6 Gfp (#32955), supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/atf6-gfp (#32955)/product/Addgene inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Endoplasmic reticulum stress signaling actively contributes to therapy resistance in colorectal cancer"
Article Title: Endoplasmic reticulum stress signaling actively contributes to therapy resistance in colorectal cancer
Journal: bioRxiv
doi: 10.1101/2024.01.07.574523
Figure Legend Snippet: (A) Frequencies of ATF4, XBP1 and/or ATF6 gene amplification in patients with major solid cancer types (left top) and Kaplan-Meier analysis of disease-free survival among cancer patients with amplified ATF4, XBP1 or ATF6 compared to patients with no alterations from the public TCGA datasets. (B) Comparison of aneuploidy scores between CRC patients with ATF6 gene amplification (ATF6 AMP ) plus/minus TP53 mutation or homozygous deletion (TP53 MUT ) and patients with no alterations (TP53 WT and/or ATF6 WT ). * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001. (C) Kaplan-Meier analysis of disease-free survival among CRC patients present with TP53 MUT and/or ATF6 AMP signatures, compared to patients with no alterations (TP53 WT and/or ATF6 WT ) from the public TCGA datasets. * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001. (D) The positivity of XBP1 and ATF6 was assessed by flow cytometry and compared between MSI group ( n = 3) and MSS group ( n = 3–4) in colon tumor and adjacent normal colon tissues. MSI, microsatellite instability. MSI, microsatellite instable; MSS, microsatellite stable or below the detection limit.
Techniques Used: Amplification, Comparison, Mutagenesis, Flow Cytometry
Figure Legend Snippet: (A) Comparison of basal gene expression levels of ATF4, (s/u)XBP1 and ATF6 between human cell lines. (B) Design of ER stress reporter genes encoded with fluorescently labelled ATF4, XBP1 or ATF6. (C) The reporter gene expression in transfected HEK293 cells was validated after treatment with Tg (1 μM, 24 h). Cut-off = 95% percentile of transfected cells without Tg treatment. (D) Total (endogenous plus exogenous) expression of ATF4, XBP1 and ATF6 in transfected HEK293 cells was analyzed by qRT-PCR after treatment with Tg (1 μM, 24 h). (E) Cross effect of the reporter gene expression on endogenous expression of the other ER stress transcription factors. Tg, Thapsigargin.
Techniques Used: Comparison, Expressing, Transfection, Quantitative RT-PCR
Figure Legend Snippet: (A) XTT assay of ER stress reporter cells to OxaPt (0–200 μM, 24 h). * p < 0.05, ** p < 0.01, compared to HEK293 WT cells. IC 50 values determined by the XTT assay ( n = 4– 5) were compared to HEK293 WT cells. (B) Total (endogenous plus exogenous) expression of ATF4, XBP1 and ATF6 in HEK293 reporter cells was analyzed by qRT-PCR after treatment with OxaPt (20 μM, 24 h). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, compared to untreated cells. OxaPt, Oxaliplatin.
Techniques Used: XTT Assay, Expressing, Quantitative RT-PCR
Figure Legend Snippet: (A) XTT cell viability assay of HCT116 and HEK293 cells treated with inhibitors for ER-stress receptors and OxaPt. HCT116 and HEK293 cells were treated with GSK2656157 (GSK’157, 10 μM, 1 h), STF083010 (STF’010, 50 μM, 1 h) or Ceapin-A7 (Ceapin, 5 or 10 μM, 6 h) prior to the treatment with OxaPt (0–200 μM, 24 h). *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, **** p ≤ 0.0001. (B) Flow cytometric analysis of apoptosis in HCT116 and HEK293 cells treated with Ceapin-A7 (ATF6 inh., 5 μM, 1 h) prior to the treatment with OxaPt (20 μM, 24 h). (C) Patient-derived organoids (PODs) were treated with Ceapin-A7 (5 μM, 6 h) prior to the treatment with OxaPt (0–20 μM, 48 h), followed by co-staining with SYTOX and Hoechst. SYTOX/Hoechst ratios (each point represent one organoid) were compared. Organoids were isolated from adjacent normal colon tissues from a stage IV CRC patient. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, compared to the vehicle control (DMSO). OxaPt, Oxaliplatin.
Techniques Used: Viability Assay, Derivative Assay, Staining, Isolation
Figure Legend Snippet: Time-lapse analysis of the ER stress inducible markers in HEK293 cells treated with OxaPt (20 μM, 0–96 h) or Tg (1 μM, 0–24 h) by (A) Western blotting and (B) XBP1 mRNA splicing assay. (C) Optical section images of HEK293 ATF6-GFP reporter and H2A-mS control cells after treatment with OxaPt (20 μM, 0–6 h) or Tg (1 μM, 0–6 h). The cells were co-stained with DAPI and anti-Golgin-97 antibody. Scale bar = 10 nm. (D) Quantification of ATF6-GFP reporter localization to nucleus or Golgi regions in HEK293 cells was evaluated and compared that of H2A-mS reporter in respective cells based on the optical section images (workflows are depicted in Fig. S5). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001, compared to the 0 h treatment. OxaPt, Oxaliplatin; Tg, Thapsigargin.
Techniques Used: Western Blot, Splicing Assay, Staining
Figure Legend Snippet: (A) The numbers of significantly down/upregulated proteins ( q ≤ 0.05) in HEK293 WT, XBP1-mN and ATF6-GFP reporter cells treated with OxaPt (20 μM, 24 h), compared to untreated condition, and overlaps of those for each cell line. (B) The numbers of significantly down/upregulated proteins ( q ≤ 0.05) in XBP1-mN and ATF6-GFP reporter cells treated with OxaPt (20 μM, 24 h) or Tg (1 μM, 24 h), compared to untreated condition, and overlaps of those for each treatment within each cell line. (C, D) Volcano plots of down/upregulated proteins in (C) XBP1-mN or (D) ATF6-GFP cells, compared to untreated conditions (left panels) and enrichment pathway analysis based on gene ontology terms performed for upregulated proteins (right panels, q ≤ 0.05). OxaPt, Oxaliplatin.
Techniques Used:
Figure Legend Snippet: (A) qRT-PCR analysis of the total (endogenous plus exogenous) expression of ATF4, XBP1 and ATF6 in HEK293 reporter cells 24 h after irradiation at 2 Gy. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, compared to that of 0 h after treatment. (B) Flow cytometric detection of the reporter gene expression in HEK293 reporter cells 30 h after irradiation at 0–8 Gy. (C) Flow cytometric analysis of apoptosis in HEK293 cells 48 h after irradiation at 0–8 Gy. (D) Colony formation assay of HEK293 reporter cells irradiated at 0–4 Gy and comparison of the survival rates between the cells irradiated at 2 Gy.
Techniques Used: Quantitative RT-PCR, Expressing, Irradiation, Colony Assay, Comparison
Figure Legend Snippet:
Techniques Used:

